Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapy

Soluble and EV-bound CD27 appear to have opposing immunomodulatory functions and may represent easily measurable, non-invasive prognostic markers to predict response and survival in patients undergoing ICI therapy.

Authors

Institutions

Publication Details

Journal
Journal of Experimental & Clinical Cancer Research
Published
2024-11-08
DOI
https://doi.org/10.1186/s13046-024-03215-4
Citations
8
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
2.26

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapy

Tom Luedde, Julian Götze, Gustav Buescher, Paul Kachel et al.
8 citations
Journal of Experimental & Clinical Cancer Research
Cancer Immunotherapy and Biomarkers
2.26
article

Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapy

Tom Luedde, Julian Götze, Gustav Buescher, Paul Kachel, Franziska Giehren, Thais Pereira‐Veiga, Kornelius Schulze, Maria Geffken, Tim H. Brümmendorf, Francesca Pagani, Sven Peine, Lorenz Kocheise, Christoph Roderburg, Alina Busch, Vincent Joerg, Marcus Altfeld, Joao Gorgulho, Constantin Schmidt, Urte Matschl, Christina C. Rolling, Sven H. Loosen, Ansgar Wilhelm Lohse, Fabian Beier, Carsten Bokemeyer, Harriet Wikman, Ramsha Masood, Britta Fritzsche, Samuel Huber, Simon Wehmeyer, Marianne Sinn, Johann von Felden, B J Schmidt, Eva Kinkel
article en
8 citations

Abstract

Soluble and EV-bound CD27 appear to have opposing immunomodulatory functions and may represent easily measurable, non-invasive prognostic markers to predict response and survival in patients undergoing ICI therapy.

Journal of Experimental & Clinical Cancer ResearchVol. 43(1)
Leibniz Institute of Virology (LIV) (DE), Universität Hamburg (DE), Düsseldorf University Hospital (DE), Integrated Oncology (United States) (US), University Medical Center Hamburg-Eppendorf (DE), University Cancer Center Hamburg (DE), ERN GUARD-Heart (NL), ERN RARE-LIVER (DE), Heinrich Heine University Düsseldorf (DE), RWTH Aachen University (DE)
Wilhelm Sander-Stiftung, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, Deutsche Krebshilfe, European Research Council, Universitätsklinikum Hamburg-Eppendorf
Openalex Percentile: Top 10%
Cancer Immunotherapy and Biomarkers
2.26
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.